NeuroOne Medical Technologies Corporation (NMTC) Total Assets by Year
NeuroOne Medical Technologies Corporation closed fiscal year 2025 with $10.8M in total assets, $3.7M in total liabilities and $7.1M in shareholder equity. This represents an increase of 100.9% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters NeuroOne Medical Technologies Corporation has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
NMTC Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.8M+100.9% | $5.4M-33.7% | $8.1M-36.9% | $12.8M+61.5% | $7.9M+66.8% | $4.8M+793.7% | $533K+143.5% | $219K-12.5% | $250K-67.0% | $757K+41082.3% | $2K+796.6% | $205-61.0% | $525-53.0% | $1K-91.9% | $14K |
| Total Liabilities | $3.7M-18.4% | $4.5M+146.1% | $1.8M-42.6% | $3.2M+132.4% | $1.4M-48.6% | $2.7M+52.2% | $1.8M-61.6% | $4.6M-12.7% | $5.3M+416.7% | $1.0M+1127.8% | $83K+134.1% | $36K+15.5% | $31K+67.9% | $18K+7.2% | $17K |
| Total Equity | $7.1M+760.4% | $822K-86.8% | $6.2M-34.9% | $9.6M+46.5% | $6.6M+217.2% | $2.1M+267.0% | -$1.2M+71.8% | -$4.4M+12.7% | -$5.0M-1791.9% | -$266K-226.7% | -$81K-130.3% | -$35K-16.8% | -$30K-75.7% | -$17K-426.0% | -$3K |
NMTC Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q/A | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q/A | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.2M-42.8% | $7.6M+69.8% | $8.6M+32.1% | $10.8M+100.9% | $10.8M+120.2% | $4.5M-17.4% | $6.5M+11.5% | $5.4M-33.7% | $4.9M-14.7% | $5.4M-25.1% | $5.8M-39.7% | $8.1M-36.9% |
| Total Liabilities | $2.4M-8.5% | $2.5M-25.2% | $2.2M-38.9% | $3.7M-18.4% | $2.6M+39.0% | $3.3M+116.2% | $3.6M+153.5% | $4.5M+146.1% | $1.9M+3.5% | $1.5M-7.9% | $1.4M-5.7% | $1.8M-42.6% |
| Total Equity | $3.8M-53.9% | $5.1M+351.0% | $6.4M+118.1% | $7.1M+760.4% | $8.2M+171.5% | $1.1M-70.8% | $2.9M-33.6% | $822K-86.8% | $3.0M-23.2% | $3.9M-30.3% | $4.4M-45.9% | $6.2M-34.9% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More NeuroOne Medical Technologies Corporation financials
Frequently Asked Questions
What was NeuroOne Medical Technologies Corporation's total assets in fiscal year 2025?
NeuroOne Medical Technologies Corporation closed fiscal year 2025 with $10.8M in total assets, $3.7M in total liabilities and $7.1M in shareholder equity.
How fast is NeuroOne Medical Technologies Corporation's total assets growing?
NeuroOne Medical Technologies Corporation (NMTC) total assets rose by 100.9% year over year, from $5.4M to $10.8M in fiscal year 2025.
How has NeuroOne Medical Technologies Corporation's total assets changed over the years?
Across the 15 fiscal years this page covers, NeuroOne Medical Technologies Corporation (NMTC) total assets went from $14K in fiscal year 2011 to $10.8M in fiscal year 2025.
What was NeuroOne Medical Technologies Corporation's total assets in the most recent quarter?
NeuroOne Medical Technologies Corporation (NMTC) reported $6.2M in total assets in Q3 2026. This represents a decrease of 42.8% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what NeuroOne Medical Technologies Corporation (NMTC) reported on that line in every period on record.